A Cytoplasm-Specific Fluorescent Ligand for Selective Imaging of RNA G-Quadruplexes in Live Cancer Cells

Chemistry. 2023 Jun 19;29(34):e202300705. doi: 10.1002/chem.202300705. Epub 2023 May 2.

Abstract

The development of site-specific, target-selective and biocompatible small molecule ligands as a fluorescent tool for real-time study of cellular functions of RNA G-quadruplexes (G4s), which are associated with human cancers, is of significance in cancer biology. We report a fluorescent ligand that is a cytoplasm-specific and RNA G4-selective fluorescent biosensor in live HeLa cells. The in vitro results show that the ligand is highly selective targeting RNA G4s including VEGF, NRAS, BCL2 and TERRA. These G4s are recognized as human cancer hallmarks. Moreover, intracellular competition studies with BRACO19 and PDS, and the colocalization study with G4-specific antibody (BG4) in HeLa cells may support that the ligand selectively binds to G4s in cellulo. Furthermore, the ligand was demonstrated for the first time in the visualization and monitoring of dynamic resolving process of RNA G4s by the overexpressed RFP-tagged DHX36 helicase in live HeLa cells.

Keywords: DHX36; G4-structure resolving; RNA G-quadruplex; fluorescent G4-ligand; live cell imaging.

MeSH terms

  • Cytoplasm / metabolism
  • G-Quadruplexes*
  • HeLa Cells
  • Humans
  • Ligands
  • Neoplasms*
  • RNA / metabolism

Substances

  • Ligands
  • RNA